◆英語タイトル:SpectraScience Inc (SCIE) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011935
◆発行会社(調査会社):
GlobalData
◆発行日:2017年12月14日
◆ページ数:29
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Summary
SpectraScience Inc (SpectraScience) is a medical device company, which undertakes the design, development, manufacture and marketing of light-based technology products. The company offers its proprietary WavSTAT Optical Biopsy System to diagnose tissue health optically by using light. This system is mainly used in diagnosing colorectal cancer and also plans to extend its application to esophageal, bladder, lung and other cancers. SpectraScience has developed two products, namely, the WavSTAT mobile console and optical biopsy forceps based on this technology. The company markets its WavSTAT System in the international markets through a distribution agreement with PENTAX Europe GmbH. SpectraScience is headquartered in San Diego, California, the US.
SpectraScience Inc (SCIE) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
SpectraScience Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
SpectraScience Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
SpectraScience Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
SpectraScience Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
SpectraScience Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
SpectraScience Inc, Medical Equipment, Deal Details 10
Asset Purchase 10
SpectraScience Acquires Assets of Oncoscope 10
Venture Financing 11
Oncoscope Raises US$0.45 Million In Venture Financing 11
Oncoscope Secures An Additional US$1.1 Million In Financing 12
Partnerships 13
SpectraScience And Pentax Europe Expand Distribution Agreement For WavStat4 Optical Biopsy System 13
SpectraScience Enters Into Distribution Agreement With Pentax Europe 14
SpectraScience Expands Licensing Agreement with Duke University 15
Debt Offering 16
Spectrascience Completes Private Placement Of Debentures For US$0.05 Million 16
SpectraScience Completes Fourth Tranche Of Private Placement Of Debentures For US$0.85 Million 17
SpectraScience Completes Private Placement Of Convertible Debentures For US$0.27 Million 18
SpectraScience Completes Private Placement Of Convertible Debentures For US$0.83 Million 19
SpectraScience Completes Private Placement Of Convertible Debentures For US$0.4 Million 20
SpectraScience Completes Private Placement Of Convertible Debentures For US$0.6 Million 21
Asset Transactions 22
SpectraScience Acquires Assets of Oncoscope 22
SpectraScience Inc – Key Competitors 23
SpectraScience Inc – Key Employees 24
SpectraScience Inc – Locations And Subsidiaries 25
Head Office 25
Other Locations & Subsidiaries 25
Recent Developments 26
Product News 26
02/02/2016: SpectraScience Announces Publication of Clinical Data 26
01/19/2016: SpectraScience to Display WavSTAT Optical Biopsy System at Arab Health Conference 27
Other Significant Developments 28
Jul 19, 2016: SpectraScience Appoints AMG as Exclusive Distributor in Middle East 28
Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29
List of Tables
SpectraScience Inc, Medical Equipment, Key Facts, 2016 2
SpectraScience Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
SpectraScience Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
SpectraScience Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
SpectraScience Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
SpectraScience Inc, Deals By Market, 2011 to YTD 2017 8
SpectraScience Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
SpectraScience Acquires Assets of Oncoscope 10
Oncoscope Raises US$0.45 Million In Venture Financing 11
Oncoscope Secures An Additional US$1.1 Million In Financing 12
SpectraScience And Pentax Europe Expand Distribution Agreement For WavStat4 Optical Biopsy System 13
SpectraScience Enters Into Distribution Agreement With Pentax Europe 14
SpectraScience Expands Licensing Agreement with Duke University 15
Spectrascience Completes Private Placement Of Debentures For US$0.05 Million 16
SpectraScience Completes Fourth Tranche Of Private Placement Of Debentures For US$0.85 Million 17
SpectraScience Completes Private Placement Of Convertible Debentures For US$0.27 Million 18
SpectraScience Completes Private Placement Of Convertible Debentures For US$0.83 Million 19
SpectraScience Completes Private Placement Of Convertible Debentures For US$0.4 Million 20
SpectraScience Completes Private Placement Of Convertible Debentures For US$0.6 Million 21
SpectraScience Acquires Assets of Oncoscope 22
SpectraScience Inc, Key Competitors 23
SpectraScience Inc, Key Employees 24
SpectraScience Inc, Subsidiaries 25